Growth capital investment activity recovered substantially in Q4 following a poor third quarter, but remains low compared to recent historical averages.
Announcement follows a series of discussions with potential strategic and financial investors
Board of the UK-based listed pharmaceuticals company has agreed to the offer
Venture capital firm Felix Capital appoints Susan Lin and Julien Codorniou as its new partners
Private equity suitors could preempt the auction given the popularity of the space